/Investor DB

Amzak Health — 2020 Investments

3 investments dated 2020 · listed companies and verified rows first · show all

4D Molecular Therapeutics4dmoleculartherapeutics.cominNASDAQ: FDMTJun 2020 · $75M

4DMT is a late-stage biotechnology company that develops gene delivery systems and genetic therapeutics targeting specific tissue types for various diseases.

BiotechHealthtechEmeryville, US

David Kirn(Chief Executive Officer, President, and Co-Founder)inDavid Schaffer(Director)inTheresa Janke(Chief of Staff, Co-Founder)in

BoardSharon Tetlow(Director)Margi McLoughlin(Director)

Co-investorsBerkeley CatalystBOLD LongevityCasdin CapitalChiesi VenturesHercules Capital, Inc.Pappas Capital+8 more

Reneoreneo.deinDec 2020 · $95M

Reneo is an asset and investment management platform for decarbonizing residential real estate portfolios in Germany.

Climate TechEnterprise SoftwarePropTechGermany, DE

Lennart Börner(Founder & Co-CEO)inAlexander Graubner-Müller(Founder & Co-CEO)in

Co-investorsFoundamentalAbingworthAisling CapitalEurazeoLakestarLundbeckfonden Ventures+4 more

Reneo Pharmaceuticalsreneopharma.comDec 2020 · $95M

Xoilac TV is a free online football (soccer) live-streaming platform serving fans in Vietnam, offering Full HD match broadcasts of European, Asian, Vietnamese, and international competitions.

ConsumerMedia & EntertainmentSports Tech

Co-investorsAisling CapitalChiesi VenturesNew Enterprise Associates (NEA)Pappas CapitalRiverVest Venture PartnersAbingworth+3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.